| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1464-410X.2012.11749.X |
| P698 | PubMed publication ID | 23360086 |
| P50 | author | Alan J Wein | Q67190115 |
| P2093 | author name string | Jeffrey P Weiss | |
| Jerry G Blaivas | |||
| Donald L Bliwise | |||
| Raymond C Rosen | |||
| Marcus Drake | |||
| Marco H Blanker | |||
| Catherine E DuBeau | |||
| Roger R Dmochowski | |||
| Adonis Hijaz | |||
| Philip E V Van Kerrebroeck | |||
| P2860 | cites work | Nocturia, sleep-disordered breathing, and cardiovascular morbidity in a community-based cohort | Q21134791 |
| Finasteride for benign prostatic hyperplasia | Q24234464 | ||
| A systematic evaluation of factors associated with nocturia--the population-based FINNO study | Q24289211 | ||
| The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society | Q28202868 | ||
| Development and validation of a quality-of-life measure for men with nocturia | Q28251096 | ||
| Once nocturia, always nocturia? Natural history of nocturia in older men based on frequency-volume charts: the Krimpen study | Q44585042 | ||
| Efficacy of desmopressin (Minirin) in the treatment of nocturia: a double-blind placebo-controlled study in women | Q44637304 | ||
| Measurement characteristics of a voiding diary for use by men and women with overactive bladder | Q44721053 | ||
| Prophylactic treatment of adult nocturia with bumetanide | Q44936309 | ||
| Nocturia is an age-independent risk factor for hip-fractures in men. | Q45029448 | ||
| Behavioral versus drug treatment for overactive bladder in men: the Male Overactive Bladder Treatment in Veterans (MOTIVE) Trial | Q45330381 | ||
| A multicomponent behavioural and drug intervention for nocturia in elderly men: rationale and pilot results | Q46120672 | ||
| Celecoxib for treatment of nocturia caused by benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled study | Q46436243 | ||
| The association of nocturia with cardiac disease, diabetes, body mass index, age and diuretic use: results from the BACH survey | Q46829210 | ||
| The prevalence of nocturia and its effect on health-related quality of life and sleep in a community sample in the USA. | Q47370091 | ||
| The international prostate symptom score overestimates nocturia assessed by frequency-volume charts | Q47755001 | ||
| A prospective study of nocturia and the quality of life of elderly patients with obstructive sleep apnea or sleep onset insomnia | Q47975152 | ||
| Sleep-disordered breathing and nocturia in older adults | Q47977816 | ||
| Desmopressin orally disintegrating tablet effectively reduces nocturia: results of a randomized, double-blind, placebo-controlled trial | Q48252319 | ||
| The efficacy and safety of oral Tamsulosin controlled absorption system (OCAS) for the treatment of lower urinary tract symptoms due to bladder outlet obstruction associated with benign prostatic hyperplasia: an open-label preliminary study | Q48284803 | ||
| Obstructive sleep apnea symptoms beyond sleepiness and snoring: effects of nasal APAP therapy. | Q48314266 | ||
| Tamsulosin versus transurethral resection of the prostate: effect on nocturia as a result of benign prostatic hyperplasia | Q48316264 | ||
| Association of nocturia and mortality: results from the Third National Health and Nutrition Examination Survey | Q48326538 | ||
| Efficacy of nondrug lifestyle measures for the treatment of nocturia | Q48348510 | ||
| Desmopressin in the treatment of nocturia: a double-blind, placebo-controlled study | Q48478087 | ||
| Continuous positive airway pressure reduces nocturia in patients with obstructive sleep apnea | Q48503652 | ||
| Nocturia: impact on quality of life in a Dutch adult population | Q48593275 | ||
| Short-term effects of systematized behavioral modification program for nocturia: a prospective study | Q48615353 | ||
| Subjective efficacy of nasal CPAP therapy in obstructive sleep apnoea syndrome: a prospective controlled study | Q48752635 | ||
| Nocturia in relation to sleep, somatic diseases and medical treatment in the elderly | Q50259881 | ||
| Nocturia: a risk factor for falls in the elderly | Q50541957 | ||
| The effect of robot-assisted laparoscopic prostatectomy on nocturia. | Q51423561 | ||
| How should patients with an overactive bladder manipulate their fluid intake? | Q53157640 | ||
| Transurethral resection of the prostate for the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: how much should be resected? | Q53181926 | ||
| Combination of alfuzosin and sildenafil is superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction. | Q53242720 | ||
| Desmopressin treatment in nocturia; an analysis of risk factors for hyponatremia | Q28283197 | ||
| Saw palmetto for benign prostatic hyperplasia | Q28296308 | ||
| Nocturia Frequency, Bother, and Quality of Life: How Often Is Too Often? A Population-Based Study in Finland | Q30053007 | ||
| The relationship between objective frequency-volume chart data and the I-PSS in men with lower urinary tract symptoms | Q31097566 | ||
| Phytotherapy in the treatment of benign prostatic hyperplasia: an update | Q33591029 | ||
| Changes in nocturia after photoselective vaporization of the prostate for patients with benign prostatic hyperplasia | Q33670768 | ||
| Meta-analysis of clinical trials of permixon in the treatment of symptomatic benign prostatic hyperplasia | Q33895865 | ||
| Prevalence and correlates of nocturia in community-dwelling older adults. | Q34077348 | ||
| Updated meta-analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasia | Q34309375 | ||
| Sex differences in vasopressin V₂ receptor expression and vasopressin-induced antidiuresis | Q34599921 | ||
| Nocturia and quality of life: results from the Boston area community health survey | Q35581021 | ||
| Physiologic outcome measures for urinary incontinence | Q35673224 | ||
| Epidemiology of nocturia | Q36222094 | ||
| Nocturic frequency is related to severity of obstructive sleep apnea, improves with continuous positive airways treatment | Q36437236 | ||
| The early postoperative morbidity of transurethral resection of the prostate and of 4 minimally invasive treatment alternatives | Q36865809 | ||
| Correlates of self-reported nocturia among community-dwelling older adults | Q37214288 | ||
| Nocturia and disturbed sleep in the elderly | Q37326274 | ||
| The prevalence and causes of nocturia | Q37771607 | ||
| Silodosin: treatment of the signs and symptoms of benign prostatic hyperplasia | Q37875062 | ||
| The evaluation and treatment of nocturia: a consensus statement | Q37890031 | ||
| Nocturia Think Tank: focus on nocturnal polyuria: ICI-RS 2011. | Q37993502 | ||
| Recent patenting activities in the discovery and development of vasopressin V2 receptor agonists | Q38013154 | ||
| Implications of the most bothersome prostatism symptom for clinical care and outcomes research | Q38575402 | ||
| Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practice | Q39322787 | ||
| Changes in Detrusor Innervation with Relief of Outflow Tract Obstruction | Q39504281 | ||
| Nocturnal micturition, sleep and well-being in women of ages 40-64 years | Q40940409 | ||
| Long-term effect of loxoprofen sodium on nocturia in patients with benign prostatic hyperplasia | Q42157053 | ||
| Effect of doxazosin gastrointestinal therapeutic system 4 mg vs tamsulosin 0.2 mg on nocturia in Chinese men with lower urinary tract symptoms: a prospective, multicenter, randomized, open, parallel study | Q42606215 | ||
| Predictors of nocturia quality of life before and shortly after prostatectomy | Q42632965 | ||
| Effectiveness of tamsulosin hydrochloride and its mechanism in improving nocturia associated with lower urinary tract symptoms/benign prostatic hyperplasia | Q42873900 | ||
| Clinical guidelines for nocturia | Q43087475 | ||
| Trospium chloride improves overactive bladder symptoms: a multicenter phase III trial | Q43310817 | ||
| Exploring older peoples' experiences of nocturia: a poorly recognised urinary condition that limits participation. | Q43315445 | ||
| Once-daily administration of trospium chloride extended release provides 24-hr coverage of nocturnal and diurnal symptoms of overactive bladder: an integrated analysis of two phase III trials | Q43325794 | ||
| Multicenter phase III trial studying trospium chloride in patients with overactive bladder | Q43331903 | ||
| Relation between nocturnal voiding frequency and nocturnal urine production in older men:a population-based study | Q43810741 | ||
| Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey | Q43853947 | ||
| Efficacy of desmopressin in the treatment of nocturia: a double-blind placebo-controlled study in men. | Q43993185 | ||
| Nocturia and benign prostatic hyperplasia | Q44387044 | ||
| P433 | issue | 5 | |
| P921 | main subject | nocturia | Q1426443 |
| P304 | page(s) | 700-716 | |
| P577 | publication date | 2013-01-29 | |
| P1433 | published in | BJU International | Q4835773 |
| P1476 | title | The New England Research Institutes, Inc. (NERI) Nocturia Advisory Conference 2012: focus on outcomes of therapy | |
| P478 | volume | 111 |
| Q35535376 | Combination therapies for the management of nocturia and its comorbidities |
| Q38763883 | Correlates of Nocturia and Relationships of Nocturia With Sleep Quality and Glycemic Control in Women With Type 2 Diabetes |
| Q90579536 | Development of a multivariate prediction model for nocturia, based on urinary tract etiologies |
| Q53440913 | Effects of two nonpharmacological treatments on the sleep quality of women with nocturia: a randomized controlled clinical trial. |
| Q92522643 | Efficacy and safety of 25 and 50 μg desmopressin orally disintegrating tablets in Japanese patients with nocturia due to nocturnal polyuria: Results from two phase 3 studies of a multicenter randomized double-blind placebo-controlled parallel-group |
| Q43187832 | Frequent urination causing sleepless nights in a 64-year-old man. |
| Q38353823 | Management of nocturia in the female |
| Q34982181 | Medication adherence in the management of nocturia: challenges and solutions |
| Q64903163 | Metabolomics analysis of blood identifies potential biomarkers and possible treatment targets for nocturia. |
| Q37553981 | The Prevalence of Nocturia and Nocturnal Polyuria: Can New Cutoff Values Be Suggested According to Age and Sex? |
| Q38227703 | The evaluation and management of persistent nocturia |
Search more.